Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Asset disposition
Quarterly results
CC transcript

CHINA MEDICINE CORP (CHME) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/27/2012 8-K Quarterly results
09/13/2012 8-K Other Events
08/03/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
09/27/2011 8-K Form 8-K - Current report
08/22/2011 8-K Form 8-K - Current report
07/08/2011 8-K Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
03/23/2011 8-K Form 8-K - Current report
02/22/2011 8-K Form 8-K - Current report
02/01/2011 8-K Form 8-K - Current report
12/29/2010 8-K Form 8-K - Current report
11/29/2010 8-K Investor presentation
Docs: "Presentation materials of China Medicine Corporation"
11/19/2010 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amended and Restated Employment Agreement, by and between China Medicine Corporation and Henry Chi Fung Ho"
11/10/2010 8-K Quarterly results
Docs: "China Medicine Reports Third Quarter 2010 Financial Results - Schedules Conference Call for November 11, 2010 - - Revises Full Year Guidance - Guangzhou, China, November 10, 2010 – China Medicine Corporation , a leading manufacturer, developer and distributor of Western pharmaceuticals, traditional Chinese medicines , and other health products, today announced financial results for the third quarter ended September 30, 2010. Third Quarter 2010 Financial Performance"
08/12/2010 8-K Form 8-K - Current report
07/09/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "About China Medicine Corporation China Medicine Corporation, a comprehensive enterprise with a research and development centre, manufacturing facilities and well established sales network, engages in the production and distribution of prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The Company distributes its products to wholesale distributors, including more than 300 hospitals and 500 medicine companies that sell to over 2,000 drug stores in 28 provinces throughout China. The Company is developing a number of proprietary products for a variety of uses, including oncology, high blood pressure and the removal of toxins from food and animal feeds. For more information, please vi..."
06/02/2010 8-K Form 8-K - Current report
05/13/2010 8-K Quarterly results
Docs: "China Medicine Announces First Quarter 2010 Results and Issues Full Year Guidance · Year-over-year gross margin expansion to 30.7% from 27.5% · Expect 2010 revenue of $72-$76 million and gross margin of 33-38% Guangzhou, China, May 13, 2010 -- China Medicine Corporation , primarily a manufacturer, leading distributor and developer of Western pharmaceuticals, traditional Chinese medicines , and other nutraceuticals, today announced financial results for its first quarter 2010 and issued guidance for the full year."
05/03/2010 8-K Form 8-K - Current report
03/29/2010 8-K Form 8-K - Current report
02/19/2010 8-K/A Form 8-K - Current report [amend]
02/02/2010 8-K Asset disposition
Docs: "Certificate of Designation, Rights and Preferences, Redeemable Convertible Preferred Stock",
"China Medicine Corporation Announces Closing of Financing, New Board Member Guangzhou, China, February 2, 2010 -- China Medicine Corporation , primarily a developer, manufacturer and leading distributor in China of Western pharmaceuticals, traditional Chinese medicines , and other nutriceuticals, today announced that it has closed the equity private placement contemplated in its Stock Subscription Agreement dated December 31, 2009 with One Equity Partners , the global private equity investment arm of JPMorgan Chase & Co. At closing, China Medicine sold 4,000,000 of the Company’s common shares at $3.00 per share for $12 million in gross proceeds and 1,920,000 of its redeemable convertible preferred shares at $30 per share for $57.6 million in gross proceeds resulting in aggregate net procee..."
01/07/2010 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
Docs: "Letter of Moore Stephens Wurth Frazer and Torbet, LLP"
01/07/2010 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Stock Subscription Agreement, by and among the Company, the Executive Shareholder and the Investor",
"China Medicine Corporation Enters Into a $69.6 Million Financing Agreement with One Equity Partners Guangzhou, China, January 7, 2010 — China Medicine Corporation , primarily a leading distributor and a developer of Western pharmaceuticals, traditional Chinese medicines , and other nutriceuticals today announced that it has entered into a Stock Subscription Agreement for an equity private placement with One Equity Partners , the global private equity investment arm of JPMorgan Chase & Co. China Medicine is OEP's first investment in Greater China and reflects the firm's commitment to back aspirational management teams to accelerate the growth of their businesses. Subject to certain closing conditions, OEP has agreed to purchase 4,000,000 of the Company’s common shares at $3.00 per share and..."
12/21/2009 8-K Changes in Control of Registrant
12/14/2009 8-K Form 8-K - Current report
11/16/2009 8-K Form 8-K - Current report
10/30/2009 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Form of Equity Ownership Transfer Agreement",
"China Medicine Corporation to Acquire Pharmaceutical Manufacturer in Guangzhou Guangzhou, China, October 30, 2009 -- China Medicine Corporation , a developer and leading distributor of prescription and over-the-counter pharmaceuticals, traditional Chinese medicines , nutritional and dietary supplements, and medical devices and medical formulations, today announced that through its wholly-owned subsidiary in China- Konzern Pharmaceuticals, it has signed an equity transfer agreement to acquire 100% of equity interests in Sinoform Limited , a British Virgin Islands corporation, the sole shareholder of Guangzhou LifeTech Pharmaceuticals Co. Ltd. , a wholly-owned subsidiary of Sinoform. LifeTech is a developer, manufacturer and marketer of pharmaceuticals products and TCMs headquartered in Guan..."
08/31/2009 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/27/2009 8-K Form 8-K - Current report
06/19/2009 8-K Other Events
05/14/2009 8-K Form 8-K -- Current report
03/27/2009 8-K Form 8-K -- Current report
03/26/2009 8-K Form 8-K -- Current report
10/10/2008 8-K Form 8-K -- Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy